Hypophospatasia Treatment Market Potential Growth, Share, Demand And Analysis Of Key Players- Research Forecasts By 2033


 The global Hypophospatasia Treatment Market size is expected to be valued at US$ 16.13 Million in 2023. With the increasing alcohol consumption among people, the overall demand for hypophospatasia treatment is projected to grow at a CAGR of 5.0% between 2023 and 2033, totaling around US$ 26.27 Million by 2033. 

An increase in research and development activities is one of the major factors that is expected to boost the growth of the Hypophospatasia Treatment Market during the forecast period. In addition, the continual rise in the demand of disease specific novel treatment is anticipated to augment the market growth in the forthcoming years.

Moreover, factors such as increased government and non-profit initiatives in various countries, in order to raise public awareness about rare diseases lead to a progressive increase in the detection rate of uncommon diseases. Hence, major factors such as favorable reimbursement policies, coupled with government financing for treatment in developed nations are increasing the rate of acceptance of this therapy. Hence, these factors are projected to contribute to the revenue share of the market during the forecast period.

Request Sample Report: https://www.futuremarketinsights.com/reports/sample/REP-GB-16229?utm_source=4018419&utm_medium=Sanket

The increase in incidence of rare diseases globally, the rise in the demand for Hypophospatasia Drugs, to improve the treatment of rare diseases, and surge in government spending on healthcare infrastructure, such as favorable reimbursement for HPP, are other factors that are projected to propel the market growth. In addition, the rise in adoption of HPP medications and an increase in availability of HPP therapies, further influence the market’s revenue share. Moreover, focus on importance of patient safety, increase in the population, growth of awareness, improved healthcare infrastructure, and less stringent guidelines for rare diseases positively affects the growth of the hypophospatasia market. Also, advancements in the HPP therapy as well as government support for treatment extend profitable opportunity to the market players during the analysis period.

Key Takeaways from the Market Study

  • Global hypophospatasia treatment market was valued at US$ 36 Million by 2022-end
  • From 2018 to 2022, the market demand expanded at a CAGR of 6%
  • By Type, the Odontohypophospatasia segment of the market constitutes the bulk of the market with a market share of 48%
  • By Treatment Type, the Medication segment dominates the market with a share of 47%
  • From 2023 to 2033, Hypophospatasia Treatment sales are expected to flourish at a CAGR of 0%.
  • By 2033, the market value of Hypophospatasia Treatment is expected to reach US$ 27 Mn.

“An upsurge in financial support to researchers for developing new innovative drugs for treatment of hypophospatasia, coupled with strong product pipeline are expected to fuel the hypophospatasia treatment market over the analysis period,” remarks an FMI analyst.

Competitive Landscape

Prominent players in the hypophospatasia treatment market are Kirin Holdings Company, Vericel Corporation, Mereo BioPharma Group plc., Novartis AG, AM Pharma B.V., Alexion, Bayer AG, Enobia Pharma, and Pfizer, Inc., among others.

Recent Developments:

  • In November 2022, Rallybio, together with its partner Exscientia, has been working toward the selection of a small molecule development candidate to advance into the clinic targeting ENPP1 for the treatment of patients with hypophospatasia (HPP).
  • Significant progress has been made to identify a lead compound and generate mouse in vivo biomarker evidence to support modulation of on-target activity. Through this collaboration with a leading global HPP expert, in vivo efficacy data is expected in the second half of 2023. Following those results, both companies expect to commence investigational new drug (IND)-enabling studies.

More Valuable Insights Available

Future Market Insights offers an unbiased analysis of the global Hypophospatasia Treatment Market, providing historical data for 2018-2022 and forecast statistics from 2023-2033.

To understand opportunities in the Hypophospatasia Treatment Market, the market is segmented on the basis of type, treatment type, and end user, across seven major regions.

Key Segments Covered in the Hypophospatasia Treatment Industry Analysis

Hypophospatasia Treatment Market by Type:

·         Odontohypophospatasia

·         Pseudohypophospatasia

Hypophospatasia Treatment Market by Treatment Type:

·         Medication

o    Asfotase Alfa

o    Non-steroidal Anti-inflammatory Drugs

o    Calcitonin

o    Strensiq

·         Surgery

Hypophospatasia Treatment Market by End User:

·         Hospitals

·         Pharmacies

·         Others

Hypophospatasia Treatment Market by Region:

·         North America

·         Latin America

·         Western Europe

·         Eastern Europe

·         Asia Pacific

·         Middle East & Africa

About the Healthcare Division at Future Market Insights

The healthcare team at Future Market Insights offers expert analysis, time efficient research, and strategic recommendations with an objective to provide authentic insights and accurate results to help clients worldwide. With a repertoire of over 100+ reports and 1 million+ data points, the team has been analyzing the industry lucidly in 50+ countries for over a decade. The team provides a brief analysis on key trends including competitive landscape, profit margin, and research development efforts.

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

 

 

Comments

Post a Comment

Popular posts from this blog

Teleradiology Services Market Analysis And Demand With Forecast Overview To 2032

Image
 In 2022, it is expected that the Teleradiology Services Market would be worth around US$ 31,880.57 Million. By 2032, it is anticipated that the market for teleradiology services would reach US$5,598.3 Million. with a 19% CAGR growth forecast through 2032. The global Teleradiology Services Market is estimated to reach a market valuation of US$ 1,971.4 Million by the end of 2016 and register a CAGR of 21.0% over the forecast period (2016–2026). The growth of this market can be attributed to the favorable government initiatives regarding the adoption of teleradiology in order to provide early disease diagnosis. Besides, the application of modern-day technologies such as the adoption of cloud-based technologies, blockchain, and cryptocurrencies will lead to better efficiency and cost-effective solutions. Increasing Investments for the development of advanced solutions is augmenting the demand for the industry. Request Sample PDF Brochure: https://www.futuremarketinsights.com/reports/...
Read more

Non-Vascular Stents Market to 2032 – Global Analysis and Forecasts by Types, Technologies, Applications and End-User Verticals

Image
 The Non-Vascular Stents Market is expected to grow at a CAGR of  4.5%  over the forecast period. (2022 - 2032). The sector is expected to be valued at  US$ 1.21 billion  in 2022 and  US$ 1.9 billion by 2032. The global non-vascular stents market is expected to move forward in response to the growing demand for minimally-invasive procedures. Rising technological and material advancements are assisting in the development of specially designed stents for use in a variety of indications thereby fueling the overall non-vascular stents market growth. Non-vascular stents use small, precise incisions, resulting in scars that are smaller and less visible than those left by traditional surgical techniques, putting the patient's safety in jeopardy. The above-mentioned feature is anticipated to provide impetus to the non-vascular stents market adoption trends in coming years. Such a surgery is associated with a faster recovery period, resulting in a shorter hospital ...
Read more

From X-rays to AI: Veterinary Imaging Innovations of the Next Decade By 2022 to 2030

Image
  Between 2022 and 2030, the global veterinary imaging industry is expected to grow at a CAGR of 6.6%, from US$ 2.02 billion in 2022 to US$ 3.37 billion by 2030. A study by Future Industry Insights (FMI) predicted that by 2030, the worldwide veterinary imaging industry would bring in US$ 3.37 billion. The research study looks at the market development for veterinary imaging through 2030 in more than 20 nations. The report offers precise insights into some of the key players in the industry's crucial business strategies. According to the poll, investments are being made in the veterinary diagnostics industry as the trend towards pet humanization picks up speed. Additionally likely to fuel industry growth are governmental rules and a greater emphasis on preserving animal health. Request A Report Sample To Gain Comprehensive Insights! https://www.futuremarketinsights.com/reports/sample/rep-gb-12368 Growth will also be fueled by the expansion of the animal and pet care industry as a w...
Read more